- Home
- RYAN vs RGC Comparison
RYAN vs RGC Comparison
Compare RYAN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$25.47
Company Overview
Basic Information| Metric | RYAN | RGC |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 11.5B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RYAN | RGC |
|---|---|---|
| Price | $37.25 | $25.47 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $56.50 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 98.4K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $3,051,126,000.00 | N/A |
| Revenue This Year | $18.15 | N/A |
| Revenue Next Year | $13.74 | N/A |
| P/E Ratio | $86.72 | ★ N/A |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $37.29 | $4.02 |
| 52 Week High | $77.00 | $950.00 |
Technical Indicators
Market Signals| Indicator | RYAN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 31.29 | 46.31 |
| Support Level | N/A | $24.31 |
| Resistance Level | $59.01 | $26.42 |
| Average True Range (ATR) | 1.55 | 2.50 |
| MACD | 0.21 | -0.29 |
| Stochastic Oscillator | 14.61 | 29.32 |
Price Performance
Historical Comparison RYAN
RGC
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.